home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Purple Biotech Ltd. - American Depositary Shares (NQ:PPBT)

4.100 +0.260 (+6.77%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Purple Biotech Ltd. - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >

Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron

March 24, 2023

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Reports Biomarker Data from CM24 Phase 1 Dose Escalation Study

March 16, 2023

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial

February 14, 2023

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech's Assets Are First In Class For Solid Tumor Treatment, Analyst Says ↗

October 17, 2022

Via Benzinga

This Small-Cap Cancer Stock Has Almost 400% Upside According To This Bullish Analyst ↗

September 08, 2022

Via Benzinga

Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer

February 02, 2023

From Purple Biotech Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 01, 2023

Via Benzinga

Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments

January 03, 2023

As a subsidiary of Clalit Healthcare Services, Israel’s largest HMO, Mor Research Applications brings Purple Biotech first access to research conducted at 14 hospitals The collaboration with Mor...

From Purple Biotech Ltd.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Thursday ↗

December 08, 2022

During Thursday's trading, 138 companies set new 52-week lows.

Via Benzinga

Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis

November 15, 2022

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech to Present at the Jefferies London Healthcare Conference

November 10, 2022

From Purple Biotech Ltd.

Via GlobeNewswire

Purple Biotech Appoints Lior Fhima as Chief Financial Officer

November 02, 2022

From Purple Biotech Ltd.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 ↗

October 17, 2022

Upgrades

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 12, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022 ↗

September 08, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 21, 2022

Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 05, 2022

Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 26, 2022

Gainers

Via Benzinga

34 Stocks Moving In Thursday's Mid-Day Session ↗

March 24, 2022

Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 37.7% to $4.64. Emclaire Financial Corp (NASDAQ: EMCF) shares climbed 32.8% to $38.35 after the company and...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 25, 2022

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

March 24, 2022

Good morning, trader! It's time for another round of the biggest pre-market stock movers before the opening bell on Thursday!

Via InvestorPlace

20 Stocks Moving in Thursday's Pre-Market Session ↗

March 24, 2022

Gainers Mercurity Fintech Holding Inc. (NYSE: MFH) rose 91% to $4.03 in pre-market trading. Energy Services of America Corporation (NASDAQ: ESOA) shares rose 40% to $4.62 in pre-...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 08, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 07, 2021

Gainers Atossa Therapeutics (NASDAQ:ATOS)...

Via Benzinga

35 Stocks Moving In Monday's Mid-Day Session ↗

June 07, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) surged 60.3% to $5.93 after the company...

Via Benzinga

70 Biggest Movers From Yesterday ↗

July 30, 2021

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 07, 2021

Gainers Evofem Biosciences (NASDAQ:EVFM) shares increased by 15.4% to $1.0 during Monday's pre-market session. The market value of their outstanding shares is at $152....

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 08, 2021

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle...

Via Benzinga

22 Stocks Moving in Monday's Pre-Market Session ↗

June 07, 2021

Gainers Liminal BioSciences Inc. (NASDAQ: LMNL) rose 51.7% to $6.10 in pre-market trading. Liminal BioSciences reported the FDA approval for its Biologics License Application...

Via Benzinga

64 Biggest Movers From Friday ↗

June 07, 2021

Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com